Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27074
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBraatz, Vera-
dc.contributor.authorMartins Custodio, Helena-
dc.contributor.authorLeu, Costin-
dc.contributor.authorAgro, Luigi-
dc.contributor.authorWang, Baihan-
dc.contributor.authorCalafato, Stella-
dc.contributor.authorRayner, Genevieve-
dc.contributor.authorDoyle, Michael G-
dc.contributor.authorHengsbach, Christian-
dc.contributor.authorBisulli, Francesca-
dc.contributor.authorWeber, Yvonne G-
dc.contributor.authorGambardella, Antonio-
dc.contributor.authorDelanty, Norman-
dc.contributor.authorCavalleri, Gianpiero-
dc.contributor.authorFoong, Jacqueline-
dc.contributor.authorScheffer, Ingrid E-
dc.contributor.authorBerkovic, Samuel F-
dc.contributor.authorBramon, Elvira-
dc.contributor.authorBalestrini, Simona-
dc.contributor.authorSisodiya, Sanjay M-
dc.date2021-07-20-
dc.date.accessioned2021-07-26T05:06:58Z-
dc.date.available2021-07-26T05:06:58Z-
dc.date.issued2021-09-
dc.identifier.citationAnnals of Neurology 2021; 90(3): 464-476en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/27074-
dc.description.abstractPsychoses affecting people with epilepsy increase disease burden and diminish quality of life. We characterised post-ictal psychosis, which comprises about one-quarter of epilepsy-related psychoses, and has unknown causation. We conducted a case-control cohort study including patients diagnosed with post-ictal psychosis, confirmed by psychiatric assessment, with available data regarding epilepsy, treatment, psychiatric history, psychosis profile and outcomes. After screening 3,288 epilepsy patients, we identified 83 with psychosis: 49 had post-ictal psychosis. Controls were 98 adults, matched by age and epilepsy type, with no history of psychosis. Logistic regression was used to investigate clinical factors associated with post-ictal psychosis; univariate associations with a P-value<0.20 were used to build a multivariate model. Polygenic risk scores for schizophrenia were calculated. Cases were more likely to have seizure clustering (OR 7.59, P<0.001), seizures with a recollected aura (OR 2.49, P=0.013) and a family history of psychiatric disease (OR 5.17, P=0.022). Cases showed predominance of right temporal epileptiform discharges (OR 4.87, P=0.007). There was no difference in epilepsy duration, neuroimaging findings or anti-seizure treatment between cases and controls. Polygenic risk scores for schizophrenia in an extended cohort of post-ictal psychosis cases (58) were significantly higher than in 1,366 epilepsy controls (R2 =3%, P=6x10-3 ), but not significantly different from 945 independent patients with schizophrenia (R2 =0.1%, P=0.775). Post-ictal psychosis occurs under particular circumstances in people with epilepsy with a heightened genetic predisposition to schizophrenia, illustrating how disease biology (seizures) and trait susceptibility (schizophrenia) may interact to produce particular outcomes (post-ictal psychosis) in a common disease. This article is protected by copyright. All rights reserved.en
dc.language.isoeng-
dc.titlePost-ictal psychosis in epilepsy: A clinico-genetic study.en
dc.typeJournal Articleen
dc.identifier.journaltitleAnnals of Neurologyen
dc.identifier.affiliationInstitute of Cognitive Neuroscience, University College London, London, UKen
dc.identifier.affiliationStanley Center of Psychiatric Research, Broad Institute of Harvard and M.I.T, Cambridge, USen
dc.identifier.affiliationEpilepsy Programme, Department of Neurology, Beaumont Hospital, Dublinen
dc.identifier.affiliationFutureNeuro Research Centre, Royal College of Surgeons, Ireland, Dublinen
dc.identifier.affiliationIRCCS, Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (Full Member of the ERN EpiCARE), Bologna, Italyen
dc.identifier.affiliationDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italyen
dc.identifier.affiliationDepartment of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germanyen
dc.identifier.affiliationDepartment of Epileptology and Neurology, University of Aachen, Aachenen
dc.identifier.affiliationFutureNeuro Research Centre, Royal College of Surgeons, Ireland, Dublinen
dc.identifier.affiliationSchool of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin 2, Irelanden
dc.identifier.affiliationDepartment of Molecular and Cellular Therapeutics and FutureNeuro Research Centre, The Royal College of Surgeons in Ireland, Dublin 2, Irelanden
dc.identifier.affiliationMental Health Neuroscience Research Department, UCL Division of Psychiatry, London, UKen
dc.identifier.affiliationInstitute of Psychiatry, Psychology & Neuroscience at King's College London, London, UKen
dc.identifier.affiliationMelbourne School of Psychological Sciences, The University of Melbourne, Parkville, Australiaen
dc.identifier.affiliationClinical Neuropsychologyen
dc.identifier.affiliationUniversity of Melbourne and Royal Children's Hospital, Florey Institute and Murdoch Children's Research Institute, Melbourne, Australiaen
dc.identifier.affiliationEpilepsy Research Centreen
dc.identifier.affiliationDepartment of Neurology, Neurological and Neurosurgical Clinic of Joinville, Joinville, Brazilen
dc.identifier.affiliationDepartment of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UKen
dc.identifier.affiliationAustin Healthen
dc.identifier.affiliationChalfont Centre for Epilepsy, Bucks, UKen
dc.identifier.affiliationGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, USen
dc.identifier.affiliationMental Health Neuroscience Research Department, UCL Division of Psychiatry, London, UKen
dc.identifier.affiliationDepartment of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germanyen
dc.identifier.affiliationInstitute of Neurology, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italyen
dc.identifier.doi10.1002/ana.26174en
dc.type.contentTexten
dc.identifier.orcid0000-0002-1109-7296en
dc.identifier.orcid0000-0001-7384-3074en
dc.identifier.orcid0000-0002-2311-2174en
dc.identifier.orcid0000-0003-4580-841Xen
dc.identifier.orcid0000-0001-5639-1969en
dc.identifier.pubmedid34288049-
local.name.researcherBerkovic, Samuel F
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptNeurology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

52
checked on Dec 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.